VENTION ADVANCED TECHNOLOGIES acquired by NORDSON CORPORATION
Context
The acquisition of Vention Advanced Technologies by Nordson Corporation signifies a major step in the group’s expansion into the high-growth medtech sector. The strategic logic of this transaction hinges on a "market-balancing" maneuver, merging the target’s industry-leading technical operational depth in interventional delivery systems with the buyer’s established scale in precision fluid management. This alignment equips the combined organization with the scientific talent and manufacturing hardware necessary to address the increasing demand for minimally invasive medical solutions across North America, Europe, and Asia. This maneuver allows the organization to execute a definitive structural expansion of its technical suite, particularly in the single-use fluid management and biomaterial delivery segments.
VENTION ADVANCED TECHNOLOGIES, which reported an EBITDA margin of [members only] in 2017, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Vention Advanced Technologies is a Medical Components & Interventional Devices company based in Salem, New Hampshire, specializing in the technical development of minimally invasive delivery systems. The entity provides critical engineering solutions for the global medical technology industry, primarily focusing on the mechanical integrity of catheters, specialty medical tubing, and balloons. Rather than offering generic healthcare products, the firm operates a sophisticated manufacturing infrastructure dedicated to extrusion, nitinol forming, and complex component assembly. Its utility resides in its ability to support medical device manufacturers from initial design through full-scale industrial production.
Ent. Value
$500M–1.5bn
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (USD)
Similar deals in Life Sciences
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2017 | CHARTERHOUSE | SERB | BELGIUM | Pharma & Biotech |
| 05/2017 | PAI PARTNERS | ELITECH GROUP | FRANCE | Diagnostic Equipment |
| 04/2017 | BAIN CAPITAL / CINVEN | STADA | GERMANY | Generics / Labs |
| 03/2017 | ARDIAN | UNITHER | FRANCE | CDMO |
| 02/2017 | ECOLAB | LABORATOIRES ANIOS | FRANCE | Medical Consumables |
| 09/2016 | ARCHIMED | POLYPLUS | FRANCE | R&D Biotech |
| 09/2016 | ARDIAN / IXO PRIVATE EQUITY | LAGARRIGUE | FRANCE | Implants & Prosthetics |
| 06/2016 | BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS | ACTEON | FRANCE | Medical Devices |
| 06/2016 | PAI PARTNERS | ATOS MEDICAL | SWEDEN | Medical Consumables |
| 06/2016 | PAI PARTNERS | ETHYPHARM | FRANCE | Pharma & Biotech |
Other operations with NORDSON CORPORATION
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 08/2024 | NORDSON CORPORATION | ATRION CORPORATION | UNITED STATES | Diagnostic Equipment |
| 06/2023 | NORDSON CORPORATION | GRUPPO ARAG | ITALY | Valves, Pumps & Taps |
| 08/2022 | NORDSON CORPORATION | CYBEROPTICS | UNITED STATES | Sensors & Optics |
| 08/2021 | NORDSON CORPORATION | NDC TECHNOLOGIES | UNITED STATES | Instrumentation & Measurement |
REFERENCES
Valuation range: EV $500M–1.5bn
Revenue range: $100–200M
EBITDA range: $25–50M
EV/Revenue range: 2x - 6x
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VENTION ADVANCED TECHNOLOGIES by NORDSON CORPORATION are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: nordson corporation